How many ml are in a 5mg Mounjaro pen — and why does the volume matter?

What the SmPC tells us: 3 ml, four doses, one fixed volume

The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, sets out the fill volume for every strength in the range: 3 ml per KwikPen. For the 5mg pen, that 3 ml contains tirzepatide at a concentration of 6.67 mg/ml, which means each of the four weekly injections delivers 0.5 ml of solution, precisely enough to give you a 5mg dose. The pen's mechanism pre-sets that volume; there is no dial, no syringe and no measuring involved on the patient's side.

This design matters because it removes a whole category of dosing error. You press the injection button, the pen counts down its clicks, and the volume is handled for you. If you want to understand the click-by-click mechanics in more detail, the click count for the 5mg pen is covered separately. The practical checking habit worth building: before each injection, hold the pen up to a light source and look at the solution through the window. It should be clear and colourless to slightly yellow, with no particles. That takes about fifteen seconds and confirms the pen is undamaged and ready.

The Mounjaro KwikPen design is documented in the Mounjaro SmPC on the eMC, which is the authoritative reference for storage windows, administration technique and contraindications, information your prescriber and pharmacist work from directly.

Why the same 3 ml volume runs across every Mounjaro strength

A question our prescribers hear fairly often is whether the higher-dose pens are simply larger or contain more solution. They are not. Eli Lilly designed the KwikPen format so every strength from 2.5mg to 15mg uses an identical 3 ml cartridge. What changes between pens is the concentration of tirzepatide dissolved in that volume.

The 2.5mg pen, for instance, delivers 0.5 ml per injection at a much lower concentration (5 mg/ml) giving 2.5mg per dose. The 5mg pen steps that concentration up to 6.67 mg/ml, and by the time you reach 15mg the concentration rises to 30 mg/ml while the per-injection volume stays at 0.5 ml. This approach keeps device engineering consistent across the range, which reduces manufacturing complexity and, importantly, means patients and clinicians handle a pen that looks and feels the same at every dose level.

For a side-by-side look at dose counts across the range, the page on how many doses a Mounjaro pen contains covers each strength. If you are currently on the 7.5mg pen and want the equivalent figures, the 7.5mg pen dose count walks through the same calculation for that concentration.

The NHS medicines page for tirzepatide provides a patient-level overview of how the medicine works and what to expect, a useful complement to the more technical SmPC detail.

What the volume tells you about how long a pen lasts, and what it does not tell you

Four weekly injections of 0.5 ml equals 2 ml used from a 3 ml cartridge. The remaining 1 ml is not an extra dose; it is the overfill that manufacturers include to guarantee the stated four doses can be drawn reliably under real-world conditions, accounting for the small amount of solution displaced during priming. The NHS guidance on weight-management injections is clear that patients should not attempt to use residual solution beyond the labelled dose count.

So in practical terms: one 5mg pen covers four weeks of treatment. After the fourth injection, the pen is empty for clinical purposes even if solution remains visible in the window. Dispose of it in a sharps container promptly and begin the next pen.

This four-week cycle is why cost-per-month comparisons for Mounjaro are generally structured around a single pen. The cost context for Mounjaro in the UK sets out how private prices are typically presented and what legitimate pricing includes, consultation, prescription, clinical aftercare and delivery. Worth reading before comparing quotes.

Understanding what is in the pen is one thing; understanding whether the 5mg dose is clinically right for you is another matter entirely. Titration decisions belong with your prescriber. If you are considering starting or transferring treatment, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not a piece of software.